Original Article

You have full text access to this OnlineOpen article

Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer

  1. Zumre A. Alicikus MD1,
  2. Yoshiya Yamada MD1,
  3. Zhigang Zhang PhD2,
  4. Xin Pei PhD1,
  5. Margie Hunt MA3,
  6. Marisa Kollmeier MD1,
  7. Brett Cox MD1,
  8. Michael J. Zelefsky MD1,†,*

Article first published online: 8 NOV 2010

DOI: 10.1002/cncr.25467

Issue

Cancer

Cancer

Volume 117, Issue 7, pages 1429–1437, 1 April 2011

Additional Information

How to Cite

Alicikus, Z. A., Yamada, Y., Zhang, Z., Pei, X., Hunt, M., Kollmeier, M., Cox, B. and Zelefsky, M. J. (2011), Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer, 117: 1429–1437. doi: 10.1002/cncr.25467

Author Information

  1. 1

    Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York

  2. 2

    Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York

  3. 3

    Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York

  1. †

    Fax: (212) 639-8876

*Department of Radiation Oncology, 1275 York Avenue, New York, NY 10065

Publication History

  1. Issue published online: 18 MAR 2011
  2. Article first published online: 8 NOV 2010
  3. Manuscript Accepted: 4 JAN 2010
  4. Manuscript Revised: 24 DEC 2009
  5. Manuscript Received: 4 SEP 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (391K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gregor Goldner, Richard Pötter, Jan J. Battermann, Christian Kirisits, Maximilian P. Schmid, Samir Sljivic, Marco van Vulpen, Comparison between external beam radiotherapy (70Gy/74Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients, Radiotherapy and Oncology, 2012, 103, 2, 223

    CrossRef

  2. 2
    G. Goldner, R. Pötter, J.J. Battermann, M.P. Schmid, C. Kirisits, S. Sljivic, M. Vulpen, Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients, Strahlentherapie und Onkologie, 2012, 188, 4, 305

    CrossRef

  3. 3
    Anudh K. Jain, Ronald D. Ennis, Focal Therapy, Differential Therapy, and Radiation Treatment for Prostate Cancer, Advances in Urology, 2012, 2012, 1

    CrossRef

  4. 4
    Michael J. Zelefsky, Marisa Kollmeier, Brett Cox, Anthony Fidaleo, Dahlia Sperling, Xin Pei, Brett Carver, Jonathan Coleman, Michael Lovelock, Margie Hunt, Improved Clinical Outcomes with High–Dose Image Guided Radiotherapy Compared with Non-IGRT for the Treatment of Clinically Localized Prostate Cancer, International Journal of Radiation Oncology*Biology*Physics, 2012,

    CrossRef

  5. 5
    Ariel E. Marciscano, Matthew E. Hardee, Nicholas Sanfilippo, Management of High-Risk Localized Prostate Cancer, Advances in Urology, 2012, 2012, 1

    CrossRef

  6. 6
    Lorenza Della Donna, Chann Lagadec, Frank Pajonk, Radioresistance of prostate cancer cells with low proteasome activity, The Prostate, 2012, 72, 8
    Direct Link:
  7. 7
    Stephen S. Connolly, Paul J. Cathcart, Paul Gilmore, Michael Kerger, Helen Crowe, Justin S. Peters, Declan G. Murphy, Anthony J. Costello, Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localised prostate cancer: initial experience of 160 men, BJU International, 2012, 109, 5
    Direct Link:
  8. 8
    Nicola L. Dallas, Peter R. Malone, Adam Jones, Andrew J. Doggart, Kevin J. McConway, Paul B. Rogers, The results of real-time brachytherapy for the management of low- and intermediate-risk prostate cancer in patients with prostate volumes up to 100 mL, BJU International, 2012, 109, 12
    Direct Link:
  9. 9
    Jakob Borup Thomsen, Dennis Tideman Arp, Jesper Carl, Urethra sparing – potential of combined Nickel–Titanium stent and intensity modulated radiation therapy in prostate cancer, Radiotherapy and Oncology, 2012, 103, 2, 256

    CrossRef

  10. 10
    Michael J. Zelefsky, Xin Pei, Joanne F. Chou, Michael Schechter, Marisa Kollmeier, Brett Cox, Yoshiya Yamada, Anthony Fidaleo, Dahlia Sperling, Laura Happersett, Zhigang Zhang, Dose Escalation for Prostate Cancer Radiotherapy: Predictors of Long-Term Biochemical Tumor Control and Distant Metastases–Free Survival Outcomes, European Urology, 2011, 60, 6, 1133

    CrossRef

  11. 11
    Marisa A. Kollmeier, Michael J. Zelefsky, How to select the optimal therapy for early-stage prostate cancer, Critical Reviews in Oncology/Hematology, 2011,

    CrossRef

  12. 12
    Sung Kim, Shunhua Shen, Dirk F. Moore, Weichung Shih, Yong Lin, Hui Li, Matthew Dolan, Yu-Hsuan Shao, Grace L. Lu-Yao, Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer, European Urology, 2011, 60, 5, 908

    CrossRef

  13. 13
    Takashi Mizowaki, Kenji Takayama, Yoshiki Norihisa, Masakazu Ogura, Tomomi Kamba, Takahiro Inoue, Yosuke Shimizu, Toshiyuki Kamoto, Osamu Ogawa, Masahiro Hiraoka, Long-term outcomes of three-dimensional conformal radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with T1c-T2N0M0 prostate cancer, International Journal of Clinical Oncology, 2011,

    CrossRef

  14. 14
    V. Khoo, Radiotherapy of prostate cancer, European Journal of Cancer, 2011, 47, S298

    CrossRef

View Full Article (HTML) Get PDF (391K)